S&P 5007,748.50▲0.3% Nasdaq26,588.49▲0.5% Dow53,770.27▼0.0% Russell 2K3,045.48▲0.6% 10-Yr4.68%+0bp VIX14.55−0.73 WTI$82.68▼0.6% Gold$4,467.10▲1.9% EUR/USD1.153▼0.2% BTC$63,387▼0.0% Nikkei66,970▲2.1%
At close · Wed, Aug 12, 2026
Daily Market Updates.

US Markets

Home›US Markets›M&A & Deals›Novo Nordisk CEO defends lawsuit against Eli Lilly ove…

Novo Nordisk CEO defends lawsuit against Eli Lilly over weight-loss ads

Reported · Written up by our desk · M&A & Deals

Novo Nordisk CEO defended the company’s decision to sue Eli Lilly over the way Lilly’s weight-loss drugs are advertised, framing it as a question of fair competition, CNBC Markets reports.

The dispute centers on Novo Nordisk’s challenge to how Eli Lilly markets its weight-loss products, according to the outlet’s account of the CEO’s remarks.

← Newer storyUS charges 11 in alleged sham marriage network tied to green cards

More like this

US MarketsTwitch faces backlash over default setting to train Amazon AI
US MarketsUS startups seek to compete with China in humanoid robotics
US MarketsSK Hynix plans $720 billion AI-driven memory factory expansion
US MarketsTwitch lets users opt out of Amazon AI training by default
US MarketsWaterways Leisure Tourism sets 1:10 stock split record date for Aug. 26

Sources

CNBC MarketsNovo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.